EDIT (STOCKS)
Editas Medicine, Inc. Common Stock
$3.200000
+0.260000 (+8.84%)
Prev close: $2.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gilmore O’Neill
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $312.70M
- Employees
- 226
- P/E (TTM)
- -1.70
- P/B (TTM)
- 11.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.26 | +0.2033 | +77.21% |
|
Sep 2025 (Q3)
|
$-0.28 | $-0.30 | +0.0222 | +7.35% |
|
Jun 2025 (Q2)
|
$-0.63 | $-0.38 | -0.2454 | -63.81% |
|
Mar 2025 (Q1)
|
$-0.92 | $-0.60 | -0.3191 | -53.10% |
Financial Statements
| Revenues | $40.52M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $200.53M |
| Nonoperating Income/Loss | -$50.00K |
| Operating Expenses | $200.53M |
| Research and Development | $89.95M |
| Other Operating Expenses | $110.58M |
| Operating Income/Loss | -$160.01M |
| Income/Loss From Continuing Operations After Tax | -$160.06M |
| Income/Loss From Continuing Operations Before Tax | $40.52M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$160.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$160.06M |
| Net Income/Loss Available To Common Stockholders, Basic | -$160.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.80 |
| Diluted Earnings Per Share | -$1.80 |
| Basic Average Shares | 88,745,908 |
| Diluted Average Shares | 88,745,908 |
| Assets | $186.53M |
| Current Assets | $163.90M |
| Accounts Receivable | $15.18M |
| Other Current Assets | $148.72M |
| Noncurrent Assets | $22.64M |
| Fixed Assets | $3.54M |
| Other Non-current Assets | $19.10M |
| Liabilities | $159.25M |
| Current Liabilities | $46.25M |
| Accounts Payable | $2.61M |
| Wages | $5.22M |
| Other Current Liabilities | $38.42M |
| Noncurrent Liabilities | $113.00M |
| Equity | $27.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.29M |
| Liabilities And Equity | $186.53M |
| Net Cash Flow From Operating Activities | -$165.24M |
| Net Cash Flow From Operating Activities, Continuing | -$165.24M |
| Net Cash Flow From Investing Activities | $138.67M |
| Net Cash Flow From Investing Activities, Continuing | $138.67M |
| Net Cash Flow From Financing Activities | $40.47M |
| Net Cash Flow From Financing Activities, Continuing | $40.47M |
| Net Cash Flow | $13.90M |
| Net Cash Flow, Continuing | $13.90M |
| Comprehensive Income/Loss | -$160.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$160.33M |
| Other Comprehensive Income/Loss | -$160.33M |